The Patent Finder

Pherin Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Pherin Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 10 of 10 · Back to Pherin Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,722,652Acute treatment of social phobia
Term ended
Ended no later than Sep 9, 2025 · From the USPTO record
Term endedEnded no later than Sep 9, 2025From the USPTO record
US 6,331,534Steroids as neurochemical stimulators of the VNO to alleviate pain
Term ended
Term ended Aug 28, 2017 · From the USPTO record
Term endedTerm ended Aug 28, 2017From the USPTO record
US 6,117,860Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia
Term ended
Term ended Jul 23, 2017 · From the USPTO record
Term endedTerm ended Jul 23, 2017From the USPTO record
US 6,555,531Weight promoting composition, method, and product
Lapsed on the fee record
Ended Apr 29, 2015 · From the USPTO record
Lapsed on the fee recordEnded Apr 29, 2015From the USPTO record
US 6,544,971Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
Lapsed on the fee record
Ended Apr 8, 2015 · From the USPTO record
Lapsed on the fee recordEnded Apr 8, 2015From the USPTO record
US 7,087,430Human VNO cDNA libraries
Lapsed on the fee record
Ended Aug 8, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 8, 2014From the USPTO record
US 6,242,61919-norpregnane steroids as neurochemical initiators of change in human hypothalamic function
Lapsed on the fee record
Ended Jun 5, 2013 · From the USPTO record
Lapsed on the fee recordEnded Jun 5, 2013From the USPTO record
US 6,352,980Estrenes for inducting hypothalamic effects
Term ended
Ended no later than Jan 7, 2011 · From the USPTO record
Term endedEnded no later than Jan 7, 2011From the USPTO record
US 5,792,75719-Nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
Term ended
Term ended no later than Aug 11, 2018 · Low confidence
Term endedTerm ended no later than Aug 11, 2018Low confidence
US 5,965,552Androstane steroids as neurochemical initators of change in human hypothalamic compositions and methods
Term ended
Term ended no later than Oct 12, 2019 · Low confidence
Term endedTerm ended no later than Oct 12, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited